NAUT
Price
$0.77
Change
+$0.03 (+4.05%)
Updated
Jun 6 closing price
Capitalization
93.77M
58 days until earnings call
XOMA
Price
$25.25
Change
+$0.25 (+1.00%)
Updated
Jun 6 closing price
Capitalization
296.3M
59 days until earnings call
Interact to see
Advertisement

NAUT vs XOMA

Header iconNAUT vs XOMA Comparison
Open Charts NAUT vs XOMABanner chart's image
Nautilus Biotechnolgy
Price$0.77
Change+$0.03 (+4.05%)
Volume$234.64K
Capitalization93.77M
XOMA Royalty
Price$25.25
Change+$0.25 (+1.00%)
Volume$34.43K
Capitalization296.3M
NAUT vs XOMA Comparison Chart
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. XOMA commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a Hold and XOMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (NAUT: $0.74 vs. XOMA: $25.15)
Brand notoriety: NAUT and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 73% vs. XOMA: 62%
Market capitalization -- NAUT: $93.77M vs. XOMA: $296.3M
NAUT [@Biotechnology] is valued at $93.77M. XOMA’s [@Biotechnology] market capitalization is $296.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, both NAUT and XOMA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 3 TA indicator(s) are bullish while XOMA’s TA Score has 4 bullish TA indicator(s).

  • NAUT’s TA Score: 3 bullish, 6 bearish.
  • XOMA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, XOMA is a better buy in the short-term than NAUT.

Price Growth

NAUT (@Biotechnology) experienced а -5.37% price change this week, while XOMA (@Biotechnology) price change was +0.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

NAUT is expected to report earnings on Aug 05, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XOMA($296M) has a higher market cap than NAUT($93.8M). XOMA YTD gains are higher at: -4.300 vs. NAUT (-55.804). XOMA has higher annual earnings (EBITDA): -5.42M vs. NAUT (-75.12M). NAUT has more cash in the bank: 130M vs. XOMA (105M). NAUT has less debt than XOMA: NAUT (30.5M) vs XOMA (119M). XOMA has higher revenues than NAUT: XOMA (10.2M) vs NAUT (0).
NAUTXOMANAUT / XOMA
Capitalization93.8M296M32%
EBITDA-75.12M-5.42M1,385%
Gain YTD-55.804-4.3001,298%
P/E RatioN/AN/A-
Revenue010.2M-
Total Cash130M105M124%
Total Debt30.5M119M26%
FUNDAMENTALS RATINGS
NAUT vs XOMA: Fundamental Ratings
NAUT
XOMA
OUTLOOK RATING
1..100
6378
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
2
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
6557
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XOMA's Valuation (2) in the Biotechnology industry is in the same range as NAUT (12) in the null industry. This means that XOMA’s stock grew similarly to NAUT’s over the last 12 months.

XOMA's Profit vs Risk Rating (94) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that XOMA’s stock grew similarly to NAUT’s over the last 12 months.

XOMA's SMR Rating (95) in the Biotechnology industry is in the same range as NAUT (96) in the null industry. This means that XOMA’s stock grew similarly to NAUT’s over the last 12 months.

XOMA's Price Growth Rating (57) in the Biotechnology industry is in the same range as NAUT (65) in the null industry. This means that XOMA’s stock grew similarly to NAUT’s over the last 12 months.

XOMA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NAUT (100) in the null industry. This means that XOMA’s stock grew similarly to NAUT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAUTXOMA
RSI
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
78%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 12 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 27 days ago
80%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
83%
Bearish Trend 18 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
85%
Aroon
ODDS (%)
Bearish Trend 12 days ago
84%
Bullish Trend 12 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-3.95%
FHTX - NAUT
48%
Loosely correlated
+6.17%
KYMR - NAUT
45%
Loosely correlated
+2.35%
IMNM - NAUT
44%
Loosely correlated
+0.35%
TECH - NAUT
41%
Loosely correlated
-1.56%
NRIX - NAUT
41%
Loosely correlated
+2.76%
More

XOMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMA has been loosely correlated with GBIO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMA jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMA
1D Price
Change %
XOMA100%
+0.92%
GBIO - XOMA
39%
Loosely correlated
-1.11%
RCUS - XOMA
37%
Loosely correlated
+1.11%
LYEL - XOMA
37%
Loosely correlated
-0.15%
CRBU - XOMA
36%
Loosely correlated
+2.75%
NAUT - XOMA
35%
Loosely correlated
-3.95%
More